Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
DKFZ-Hector Cancer Institute

DKFZ-Hector Cancer Institute at the University Medical Centre Mannheim

Cancer is the second most frequent disease-related cause of death and is one of the most strongly feared diseases in Germany. In addition to better prevention and new diagnostic methods, a systematic development of patient-oriented research into personalized precision oncology is required to address cancer in a targeted and successful way. Comprehensive cancer centers (CCC) around the world, which bring together outstanding research with excellent multidisciplinary oncological care, are driving forward patient-oriented cancer research. To establish the "DKFZ-Hector Cancer Institute at the University Medical Center Mannheim" DKFZ, University Medical Center Mannheim and Medical Faculty Mannheim at the University Heidelberg have entered a partnership to perform patient-oriented translational cancer research on an internationally competitive level. This long-term partnership will be funded by the Hector Foundation II for the next ten years, with generous support of € 2.5 million a year.

The "DKFZ-Hector Cancer Institute at the University Medical Center Mannheim" is supported by the DKFZ, which offers the necessary scientific environment to perform translational-clinical research on an international top-level. The University Medical Center Mannheim and Medical Faculty Mannheim offers quality-assured multidisciplinary patient care, research, and teaching at the highest level.

The "DKFZ-Hector Cancer Institute at the University Medical Center Mannheim" will focus on the translation of research findings at DKFZ and Medical Faculty Mannheim into innovative clinical trials. The aim is to establish a translational continuum via optimal cooperation between cancer researchers and physicians. Herewith, transfer of results from cutting-edge research into patient care and the reverse translation of findings from clinical practice will be accelerated to foster advances for cancer patients.

For this purpose, the three partners are contributing their expertise in the field of cancer research and cancer medicine to the cooperation in order to establish a national model institution in Mannheim with international appeal.

The core of the "DKFZ-Hector Cancer Institute at the University Medical Center Mannheim" will be a patient-oriented translational outpatient clinic, which will be established to translate basic and preclinical research findings into clinical trials (from bench to bedside). At the same time clinical data and biomaterials will be made available for preclinical and basic research in a systematic approach (reverse translation).

to top
powered by webEdition CMS